Johnson & Johnson's Fiscal Year is From January To December - All Figures are in USD.
The item "Diluted-EPS" stands at 10.36 United States Dollars for the trailing twelve months (TTM) period ending 09/30/2025, the highest value since 09/30/2024.
Johnson & Johnson's third quarter result of 2.12 USD for the item "Diluted EPS" represents a decrease of -7.32 percent compared to it's second quarter result.
Also, Johnson & Johnson's third quarter result of 2.12 USD for the item "Diluted EPS" represents an increase of 91.18 percent compared to it's third quarter result of last year.
Looking again at the trailing twelve months series (TTM), Johnson & Johnson's third quarter result of 10.36 USD for the item "Diluted EPS" represents an increase of 10.82 percent compared to it's second quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 71.28 percent compared to the value the year prior.
The 1 year change in percent is 71.28.
The 3 year change in percent is 44.23.
The 5 year change in percent is 62.82.
The 10 year change in percent is 98.62.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Diluted EPS | 905,699,262,464.00 |
![]() | AbbVie Inc - Diluted EPS | 399,570,305,024.00 |
![]() | Roche Holding AG - Diluted EPS | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Diluted EPS | 280,205,508,085.11 |
![]() | Novartis AG - Diluted EPS | 255,096,620,580.91 |